Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy

被引：3
|
作者：
Montefiori, David C. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Surg, Lab AIDS Vaccine Res & Dev, Durham, NC 27710 USA
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2014年 / 10卷 / 08期
关键词：
neutralizing antibodies; HIV; vaccines; correlates; sieve; STANDARDIZED ASSESSMENTS; MONOCLONAL-ANTIBODIES; CHIMERIC VIRUS; ENV CLONES; PROTECTION; INFECTION; RESPONSES; ASSAY; TRANSMISSION; IMMUNIZATION;
D O I：
10.4161/hv.28950
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2507 / 2511
页数：5
相关论文
共 50 条
  • [31] Humoral immunity to HIV-1: neutralization and beyond
    Huber, M.
    Trkola, A.
    JOURNAL OF INTERNAL MEDICINE, 2007, 262 (01) : 5 - 25
  • [32] Unraveling the structural basis of HIV-1 neutralization
    Wright, Elizabeth R.
    Spearman, Paul W.
    FUTURE MICROBIOLOGY, 2012, 7 (11) : 1251 - 1254
  • [33] Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
    Brandenberg, Oliver F.
    Magnus, Carsten
    Rusert, Peter
    Guenthard, Huldrych F.
    Regoes, Roland R.
    Trkola, Alexandra
    PLOS PATHOGENS, 2017, 13 (05)
  • [34] Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV-1 gp120 Vaccine
    Gilbert, Peter
    Wang, Maggie
    Wrin, Terri
    Petropoulos, Chris
    Gurwith, Marc
    Sinangil, Faruk
    D'Souza, Patricia
    Rodriguez-Chavez, Isaac R.
    DeCamp, Allan
    Giganti, Mike
    Berman, Phillip W.
    Self, Steve G.
    Montefiori, David C.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (04) : 595 - 605
  • [35] Enhanced HIV-1 neutralization by antibody heteroligation
    Mouquet, Hugo
    Warncke, Malte
    Scheid, Johannes F.
    Seaman, Michael S.
    Nussenzweig, Michel C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (03) : 875 - 880
  • [36] Antibody Epitope Exposure and Neutralization of HIV-1
    Pantophlet, Ralph A.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (33) : 3729 - 3743
  • [37] The Importance of Antibody Isotype in HIV-1 Virus Capture Assay and in TZM-bl Neutralization
    Peachman, Kristina K.
    Wieczorek, Lindsay
    Matyas, Gary R.
    Polonis, Victoria R.
    Alving, Carl R.
    Rao, Mangala
    VIRAL IMMUNOLOGY, 2010, 23 (06) : 627 - 632
  • [38] Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines
    Longini, IM
    Datta, S
    Halloran, ME
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (05): : 440 - 447
  • [39] Antibody class-switching as a strategy to improve HIV-1 neutralization
    Scheepers, Cathrine
    Richardson, Simone I.
    Moyo-Gwete, Thandeka
    Moore, Penny L.
    TRENDS IN MOLECULAR MEDICINE, 2022, 28 (11) : 979 - 988
  • [40] HIV-1 infections with multiple founders associate with the development of neutralization breadth
    Lewitus, Eric
    Townsley, Samantha M.
    Li, Yifan
    Donofrio, Gina C.
    Dearlove, Bethany L.
    Bai, Hongjun
    Sanders-Buell, Eric
    O'Sullivan, Anne Marie
    Bose, Meera
    Kibuuka, Hannah
    Maganga, Lucas
    Nitayaphan, Sorachai
    Sawe, Fredrick K.
    Eller, Leigh Anne
    Michael, Nelson L.
    Polonis, Victoria R.
    Ake, Julie A.
    Vasan, Sandhya
    Robb, Merlin L.
    Tovanabutra, Sodsai
    Krebs, Shelly J.
    Rolland, Morgane
    PLOS PATHOGENS, 2022, 18 (03)
12345